Challenges of drug resistance in the developing world
暂无分享,去创建一个
[1] I. Okeke,et al. Non-prescription antimicrobial use worldwide: a systematic review. , 2011, The Lancet. Infectious diseases.
[2] N. Ganguly,et al. India's vaccine deficit: why more than half of Indian children are not fully immunized, and what can--and should--be done. , 2011, Health affairs.
[3] Jerker Fick,et al. Transparency throughout the production chain--a way to reduce pollution from the manufacturing of pharmaceuticals? , 2009, Regulatory toxicology and pharmacology : RTP.
[4] T. West,et al. Staphylococcus aureus Bacteraemia in a Tropical Setting: Patient Outcome and Impact of Antibiotic Resistance , 2009, PloS one.
[5] R. Dagan,et al. Impact of conjugate pneumococcal vaccines on antibiotic resistance. , 2008, The Lancet. Infectious diseases.
[6] B. Marston,et al. Does cotrimoxazole prophylaxis for the prevention of HIV-associated opportunistic infections select for resistant pathogens in Kenyan adults? , 2008, The American journal of tropical medicine and hygiene.
[7] A. Apisarnthanarak,et al. Nonjudicious Dispensing of Antibiotics by Drug Stores in Pratumthani, Thailand , 2008, Infection Control & Hospital Epidemiology.
[8] W. Schaffner,et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. , 2006, The New England journal of medicine.
[9] David L Heymann,et al. Resistance to Anti-Infective Drugs and the Threat to Public Health , 2006, Cell.
[10] P. Chilonda,et al. Old players, new players. , 2006 .
[11] Ramanan Laxminarayan,et al. Antimicrobial resistance in developing countries. Part I: recent trends and current status. , 2005, The Lancet. Infectious diseases.
[12] H. Goossens,et al. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study , 2005, The Lancet.
[13] Aryanti Radyowijati,et al. Improving antibiotic use in low-income countries: an overview of evidence on determinants. , 2003, Social science & medicine.
[14] B. Lowe,et al. Diagnosis of acute bacterial meningitis in children at a district hospital in sub-Saharan Africa , 2001, The Lancet.
[15] S. Madhi,et al. Increased disease burden and antibiotic resistance of bacteria causing severe community-acquired lower respiratory tract infections in human immunodeficiency virus type 1-infected children. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[16] V. Diwan,et al. HEALTH FINANCING POLICIES , 1999, International Journal of Technology Assessment in Health Care.
[17] V. Diwan,et al. Association between health insurance and antibiotics prescribing in four counties in rural China. , 1999, Health policy.
[18] R. Huebner,et al. The impact of HIV on Streptococcus pneumoniae bacteraemia in a South African population , 1998, AIDS.
[19] I. Okeke,et al. Antimicrobial resistance in developing countries , 1998, BMJ.
[20] E. Lagarde,et al. Impact of chloroquine resistance on malaria mortality. , 1998, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.
[21] J. Vincent,et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. , 1995, JAMA.
[22] Lim Vk,et al. Bacteriology turnaround time in seven Malaysian general hospitals. , 1992 .
[23] S. Kariuki,et al. Analysis of economic incentives influencing farmers' use of antibiotics in livestock production in Kenya. Final report , 2011 .
[24] Jay Steingrub,et al. International study of the prevalence and outcomes of infection in intensive care units , 2009 .
[25] Organización Mundial de la Salud. Community-based surveillance of antimicrobial use and resistance in resource-constrained settings: report on five pilot projects , 2009 .
[26] James A. Roberts,et al. The economics of infectious disease , 2006 .
[27] Y. Cheong,et al. Bacteriology turnaround time in seven Malaysian general hospitals. , 1992, The Malaysian journal of pathology.